Trials / Completed
CompletedNCT01361620
Genotypic and Phenotypic Correlates of Resistance to Aspirin
Genotypic and Phenotypic Correlates of Resistance to Anti-platelet Actions of Aspirin in an At-risk Patient Population and in the General Population
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 190 (actual)
- Sponsor
- George Washington University · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The study seeks to identify genomic markers associated with aspirin resistance.
Detailed description
Not desired
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | aspirin | aspirin 81mg, 7-10 days |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2011-04-01
- Completion
- 2011-04-01
- First posted
- 2011-05-27
- Last updated
- 2013-12-16
- Results posted
- 2013-12-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01361620. Inclusion in this directory is not an endorsement.